Patients with a Wolff-Parkinson-White (WPW) pattern on their ECG can experience symptoms such as syncope, palpitations, supraventricular tachycardia, and atrial fibrillation, or they can be asymptomatic (aWPW). All patients with WPW, regardless of the presence or absence of symptoms, are at risk of sudden death. Therefore, it is recommended that younger patients with WPW undergo studies to determine their risk. We report a previously asymptomatic WPW patient identified as high risk for sudden death due to rapid conduction down her accessory pathway during atrial fibrillation induced during a trans-esophageal electrophysiology study.
Background
Approximately 0.15% of the general population is affected with Wolff-Parkinson-White (WPW) syndrome [1] . The presence of symptoms, such as syncope, palpitations, supraventricular tachycardia, atrial fibrillation (A fib) M. Gupta et al.
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or sudden death (SCD) in addition to the ECG findings of a short PR interval and the presence of a delta wave meets the criteria initially spelled out by Drs. Wolff, Parkinson and White for the diagnosis of WPW [2] . Many patients with aWPW pattern on their ECG do not manifest symptoms and are subsequently referred to as either asymptomatic ventricular pre-excitation or asymptomatic Wolff-Parkinson-White (aWPW) [3] - [4] . The exact number of patients with aWPW remains unknown, but it is accepted to be approximately 50% of all WPW patients [3] - [4] .
Regardless of symptomatology, all patients with WPW are capable of rapid conduction down their accessory pathway (AP) during atrial fibrillation (A fib) which can lead to ventricular fibrillation and SCD [5] - [7] . Although the overall incidence of SCD in WPW patients is low, estimated at approximately 4.5 per 1000 patient-years, the catastrophic nature of this manifestation suggests an important role for risk stratification and treatment for those who are at risk [8] . A number of methods are currently available to risk assessment of WPW patients, ranging from non-invasive studies such as exercise stress testing (EST) to invasive studies including trans-esophageal or trans-venous electrophysiology studies [9] [10] .
We report on a previously asymptomatic WPW patient identified as high risk for SCD due to rapid conduction down her accessory pathway during A fib, shortest pre-excited RR interval of 172 msec, induced during a transesophageal electrophysiology study.
Case Report
A previously healthy 16-year-old female was referred for evaluation of chest pain. Her history and physical examination were unremarkable, but her ECG revealed WPW (Figure 1 ). Because she was asymptomatic, the decision was made to risk assessing her proceeding from non-invasive (EST) to invasive (transvenous electrophysiology study) testing.
During her exercise stress test, the accessory pathway persisted to the peak heart rate of 205 bpm. Due to the fact that her ECG did not normalize (loss of pre-excitation), her risk could not be determined. She subsequently underwent a minimally invasive transesophageal electrophysiology study (TEEPS).
The TEEPS was performed under general mask anesthesia using a single, 5 French trans-esophageal electrophysiology catheter (TAPCATH 205 ® bipolar pacing and recording catheter). The catheter was passed via the naso-esophageal route and placed in her mid esophagus where atrial tracings were noted. After atrial pacing was confirmed, atrial burst pacing was performed to a cycle length of 200 milliseconds until A fib was induced (Figure 2) Her shortest preexcited R-R interval during A fib measured 172 msec, placing her at high risk for SCD. Due to this risk, her TEEPS was converted to a transvenous electrophysiology study where her AP was located and successfully ablated (Figure 3 ).
Discussion
In symptomatic patients with WPW, current practice dictates that these patients benefit from a transvenous electrophysiology study because the accessory pathway can be both risk-assessed and ablated during the same procedure. Currently, no guidelines exist for the management of aWPW patients.
A previous Italian study [11] which followed 184 asymptomatic children with WPW pattern on their ECG, found 19 patients during 60 months follow-up who developed potentially life threatening arrhythmias and three of these patients died secondary to these tachyarrhythmias.
In an effort to risk assessing patients with aWPW, our institution developed an algorithm for risk stratification which progresses from least to most invasive testing [12] (Table 1 and Figure 4 ).
Asymptomatic WPW Algorithm
This decision tree commences with a non-invasive EST. During this test, the physician monitors the patients ECG for either normalization of the QRS or loss of preexcitation. If the patient does not lose preexcitation during the EST, then their risk cannot be determined. While EST is easily performed in the office on the same day of evaluation, the disadvantage is that the EST provides successful risk assessment in only 8% of all aWPW patients [13] [14] .
If the EST fails to risk assessing a patient, then the next step in our algorithm is to perform a transesophageal electrophysiology study; as this test is minimally invasive, requires no intravenous access, only limited anesthesia, and saving patient from invasive transvenous electrophysiology study. During TEEPS, if A fib is successfully induced and the shortest pre-excited RR interval is equal to or greater than 250 millliseconds then there is no risk of SCD and no further testing is required. If A fib is not inducible or the shortest pre-excited RR interal during A Fib is less than 250 milliseconds, then the next step in the algorithm is to perform a transvenous electrophysiology study [12] .
In our patient, we were able to induce A fib with TEEPS where her shortest RR interval was 172 milliseconds, placing her at high risk for sudden cardiac death. Due to her risk, the TEEPS was converted to a transvenous electrophysiology study at which time the accessory pathway was localized and successfully ablated. On her follow up visits, she is asymptomatic from a cardiovascular standpoint with no evidence of preexcitation on her ECG. 
Conclusion
This report describes the identification of a previously asymptomatic patient with Wolff-Parkinson-White as one who has high risk for sudden cardiac death. This documentation of her risk was performed using the minimally invasive transesophageal procedure. Performance of this procedure on previously asymptomatic patients with Wolff-Parkinson-White syndrome can be very helpful in determining their risk for sudden cardiac death.
